ESTRATAB Drug Patent Profile
Which patents cover Estratab, and when can generic versions of Estratab launch?
Estratab is a drug marketed by Solvay and is included in four NDAs.
The generic ingredient in ESTRATAB is estrogens, esterified. There is one drug master file entry for this compound. Additional details are available on the estrogens, esterified profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ESTRATAB?
- What are the global sales for ESTRATAB?
- What is Average Wholesale Price for ESTRATAB?
Summary for ESTRATAB
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 35 |
| Patent Applications: | 1,832 |
| DailyMed Link: | ESTRATAB at DailyMed |
US Patents and Regulatory Information for ESTRATAB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | ESTRATAB | estrogens, esterified | TABLET;ORAL | 086715-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Solvay | ESTRATAB | estrogens, esterified | TABLET;ORAL | 083857-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Solvay | ESTRATAB | estrogens, esterified | TABLET;ORAL | 083209-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Solvay | ESTRATAB | estrogens, esterified | TABLET;ORAL | 083856-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
